Carol Colborn Loepere Photo

Carol advises health care, life sciences and private equity clients on the regulatory requirements and business considerations in connection with health care transactions, including mergers, acquisitions and divestitures, public offerings, investments in health care companies and financing transactions. Carol’s extensive health regulatory experience helps guide parties on due diligence, change of ownership issues, regulatory approvals and related regulatory issues. In addition, she guides clients on compliance with physician self-referral and anti-kickback laws, and with beneficiary inducement and exclusion issues, and she represents clients in payor audits and False Claims Act investigations and proceedings.


  • New York University School of Law, 1984, J.D.
  • Harvard University, Radcliffe College, 1981, B.A., Phi Beta Kappa

  • District of Columbia

  • U.S. Court of Appeals - Seventh Circuit
  • U.S. District Court - District of Columbia

  • American Health Lawyers Association
  • District of Columbia Bar Association
  • Women's Bar Association – past chair of the Health Law Forum


  • Selected through peer review for inclusion in The Best Lawyers in America© for Health Care Law, 2021-2024
  • Listed as a Leading Lawyer in The Legal 500 USA for Healthcare: service providers (2013-2019)
  • Named a “Life Sciences Star” (Regulatory) in the LMG Life Science Guide (2013-2021) and a “Life Sciences Star” for Healthcare Pricing & Reimbursement in the LMG Life Sciences Guide (2022-2023)
  • Named in the 2010 and 2012 BTI Client Service All-Star Teams
  • Ranked in Chambers USA for District of Columbia Healthcare, 2009-2024
  • Recognized by Washingtonian magazine as a Top Lawyer in the area of health care law (2013-2014)

Notable Quotes

  • 4 December 2023 "Meet the 5 most active PE investors in life sciences" PitchBook